Estimating The Expression Patterns Of Fn3K Nrf2 Nqo1 In Breast Tumors And Development Of Fn3K Blockers To Modulate Nrf2 Glycation  Drug Combination Studies

dc.contributor.guide	Gurupadayya, B M
dc.coverage.spatial	Pharmacy
dc.creator.researcher	Narasimha Murthy, Beeraka
dc.date.accessioned	2023-01-09T11:50:50Z
dc.date.available	2023-01-09T11:50:50Z
dc.date.awarded	2023
dc.date.completed	2022
dc.date.registered	2020
dc.description.abstract	Available
dc.description.note	summary 227-229 References 230-255
dc.format.accompanyingmaterial	CD
dc.format.dimensions	3
dc.format.extent	1-258 p
dc.identifier.uri	http://hdl.handle.net/10603/439971
dc.language	English
dc.publisher.institution	Colleges of Pharmacy
dc.publisher.place	Mysore
dc.publisher.university	JSS Academy of Higher Education and Research
dc.relation	427
dc.rights	university
dc.source.university	University
dc.subject.keyword	Breast Cancer, Nrf2, Fructosamine-3-kinase, glycation, deglycation, Molecular Biology, Proteomics, Prognostics, Molecular dyanmic simulations
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Estimating The Expression Patterns Of Fn3K Nrf2 Nqo1 In Breast Tumors And Development Of Fn3K Blockers To Modulate Nrf2 Glycation Drug Combination Studies
dc.title.alternative
dc.type.degree	Ph.D.